Systemic lupus erythematosus in Hispanics

Autoimmunity

Volumn 44, Issue 7, 2011, Pages 555-561

  Atisha Fregoso, Yemil ^a   Jakez Ocampo, Juan ^a   Llorente, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Ethnicity; Hispanics; Systemic lupus erythematosus

Indexed keywords

CHLOROQUINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC ASSOCIATION; HEALTH CARE ACCESS; HISPANIC; KIDNEY DISEASE; MORTALITY; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HISPANIC AMERICANS; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE;

EID: 80053975398     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.592882     Document Type: Article

References (55)

1. Wang S, Ray N, Rojas W, Parra MV, Bedoya G, Gallo C, Poletti G, Mazzotti G, Hill K, Hurtado AM, Camrena B, Nicolini H, Klitz W, Barrantes R, Molina JA, Freimer NB, Bortolini MC, Salzano FM, Petzl-Erler ML, Tsuneto LT, Dipierri JE, Alfaro EL, Bailliet G, Bianchi NO, Llop E, Rothhammer F, Excoffier L, Ruiz-Linares A. Geographic patterns of genome admixture in Latin American Mestizos. PLoS Genet 2008;4(3):e1000037.
2. Senior PA, Bhopal R. Ethnicity as a variable in epidemiological research. BMJ 1994;309:327-330. (Pubitemid 24236436)
3. Ford ME, Kelly PA. Conceptualizing and categorizing race and ethnicity in health services research. Health Serv Res 2005;40:1658-1675. (Pubitemid 41434353)
4. Molineros JE, Kim-Howard X, Deshmukh H, Jacob CO, Harley JB, Nath SK. Admixture in Hispanic Americans: Its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun 2009;10:539-545.
5. SeldinMF, Qi L, Scherbarth HR, Tian C, Ransom M, Silva G, Belmont JW, Gamron S, Allievi A, Palatnik SA, Saurit V, Paira S, Graf C, Guilleroń C, Catoggio LJ, Prigione C, Berbotto GA, García MA, Perandones CE, Truedsson L, Abderrahim H, Battagliotti CG, Pons-Estel BA, Alarcon-Riquelme ME. Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus. Genes Immun 2008;9: 389-393. (Pubitemid 351791496)
6. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F, Alvarellos A, Alarcoń-Segovia D. Grupo Latinoamericano de Estudio del Lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: Ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore) 2004;83:1-17. (Pubitemid 38124852)
7. Alarcoń GS. Lessons from LUMINA: A multiethnic US cohort. Lupus 2008;17:971-976.
8. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50. (Pubitemid 29042569)
9. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: Clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998;27:98-105. (Pubitemid 28172565)
10. Lim SS, Drenkard C. Epidemiology of systemic lupus erythematosus: Capturing the butterfly. Curr Rheumatol Rep 2008;10:265-272.
11. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 2006;15:308-318. (Pubitemid 43828810)
12. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-2094.
13. Molina MJ, Mayor AM, Franco AE, Morell CA, Loṕez MA, Vilá LM. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J Clin Rheumatol 2007;13:202-204. (Pubitemid 47356788)
14. Alarcoń GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, McGwin G, Jr, Bartolucci AA, Roseman JM, Reveille JD. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus in minority populations: Nature vs. nurture. Lupus 1999;8:197-209. (Pubitemid 29186838)
15. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, Roubey RA, Dooley MA. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002;11:161-167. (Pubitemid 34296931)
16. Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, Babini JC, Catoggio LJ, Alarcon-Segovia D. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005;14:938-946. (Pubitemid 43088267)
17. Alarcoń-Segovia D, Alarcoń-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA. Grupo Latinoamericano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138-1147. (Pubitemid 40530121)
18. Rhodes B, Vyse TJ. The genetics of SLE: An update in the light of genome-wide association studies. Rheumatology 2008; 47:1603-1611.
19. Castaño-Rodríguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev 2008;7: 322-330.
20. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, Straaton KV, Alarcoń GS. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1161-1172. (Pubitemid 28313416)
21. Vargas-Alarcoń G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J, Arnaiz-Villena A, Alarcoń-Segovia D, Class II. allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: The relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol 2001;62:814-820. (Pubitemid 32703349)
22. Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, Chen W, Zhu C, McEver RP, Kimberly RP, Alarcoń-Riquelme ME, Vyse TJ, Li QZ, Wakeland EK, Merrill JT, James JA, Kaufman KM, Guthridge JM, Harley JB. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008;40:152-154. (Pubitemid 351171399)
23. Reddy MV, Velázquez-Cruz R, Baca V, Lima G, Granados J, Orozco L, Alarcoń-Riquelme ME. Genetic association of IRF5 with SLE in Mexicans: Higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 2007;121:721-727. (Pubitemid 46916971)
24. Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP Jr, Reiff A, Myones BL, Guthridge JM, Nath SK, Bruner GR, Mehrian-Shai R, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Putterman C, Bae SC, Kim YJ, Petri M, Reveille JD, Vyse TJ, Gilkeson GS, Kamen DL, Alarcoń-Riquelme ME, Gaffney PM, Moser KL, Merrill JT, Scofield RH, James JA, Langefeld CD, Harley JB, Jacob CO. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum 2009;60(4):1085-1095.
25. Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ, Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002;169:4388-4398. (Pubitemid 35178213)
26. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007;178:4901-4907. (Pubitemid 46595272)
27. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010;9:A277-A287.
28. Calvo-Alén J, Reveille JD, Rodríguez-Valverde V, McGwin G, Jr, Baethge BA, Friedman AW, Alarcoń GS. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003;12:377-385. (Pubitemid 36596982)
29. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, Straaton KV, Alarcoń GS. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1161-1172. (Pubitemid 28313416)
30. Alarcoń GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, Straaton KV, Reveille JD; LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1173-1180.
31. Alarcoń GS, Calvo-Alén J, McGwin G, Jr, Uribe AG, Toloza SM, Roseman JM, Fernández M, Fessler BJ, Vilá LM, Ahn C, Tan FK, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006;65:1168-1174. (Pubitemid 44277391)
32. Alarcoń GS, McGwinG Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, Bastian HM, Friedman AW, Reveille JD; LUMINA Study Group. Lupus in minority populations, nature versus nurture. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 2001;44: 2797-2806.
33. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcoń G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H,McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-2557. (Pubitemid 44205016)
34. Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006;69:1846-1851. (Pubitemid 43739214)
35. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, Radhakrishnan J. Prognosis in proliferative lupus nephritis: The role of socioeconomic status and race/ethnicity. Nephrol Dial Transplant 2003;18:2039-2046. (Pubitemid 37220309)
36. Alarcoń GS, Bastian HM, Beasley TM, Roseman JM, Tan FK, Fessler BJ, Vilá LM, McGwin G Jr; LUMINA Study Group. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] Contributions of admixture and socioeconomic status to renal involvement. Lupus 2006; 15:26-31. (Pubitemid 43266125)
37. González LA, Pons-Estel GJ, Zhang J, Vilá LM, Reveille JD, Alarcoń GS; LUMINA Study Group. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): A multi-ethnic lupus cohort. Lupus 2009;18:822-830.
38. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, Gomez LJ, Felipe O, Ramirez LA, Alarcon-Segovia D. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 1996;75: 124-130. (Pubitemid 26159209)
39. Uribe AG, Romero-Díaz J, Apte M, Fernández M, Burgos PI, Reveille JD, Sánchez-Guerrero J, Alarcoń GS. Impact of immigration on the clinical expression of systemic lupus erythematosus: A comparative study of Hispanic patients residing in the USA and Mexico. Rheumatology (Oxford) 2009;48:1392-1397.
40. Vilá LM, Alarcoń GS, McGwin G Jr, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 2004;43:358-363. (Pubitemid 38313188)
41. Fernández M, Alarcoń GS, Calvo-Alén J, Andrade R, McGwin G Jr, Vilá LM, Reveille JD; LUMINA Study Group. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007;15: 576-584. (Pubitemid 46764046)
42. Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sánchez-Guerrero J, Wofsy D, Yu X, Solomons N. Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study. Rheumatology (Oxford) 2010; 49:128-140.
43. Alarcoń GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Alén J, Bastian HM, Vilá LM, Reveille JD. Effect of hydroxychloroquine in the survival of patients with systemic lupus erythematosus. Data from LUMINA, a multiethnic us cohort (LUMINA L). Ann Rheum Dis 2007;66:1168-1172. (Pubitemid 47309732)
44. Shinjo SK, Bonfá E, Wojdyla D, Borba EF, Ramirez LA, Scherbarth HR, Brenol JC, Chacoń-Diaz R, Neira OJ, Berbotto GA, De La Torre IG, Acevedo-Vázquez EM, Massardo L, Barile-Fabris LA, Caeiro F, Silveira LH, Sato EI, Buliubasich S, Alarcoń GS, Pons-Estel BA. Grupo Latino Americano de Estudio del Lupus Eritematoso (Gladel). Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort. Arthritis Rheum 2010;62:855-862.
45. Hernández-Cruz B, Tapia N, Villa-Romero AR, Reyes E, Cardiel MH. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol 2001;19: 395-401. (Pubitemid 32691112)
46. SisóA, Ramos-Casals M, Bové A, Brito-Zeroń P, Soria N, Muñoz S, Testi A, Plaza J, Sentís J, Coca A. Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival. Lupus 2008; 17:281-288. (Pubitemid 351655794)
47. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, Garmendia M, Villar I, Martinez-Berriotxoa A, Erdozain JG, Aguirre C. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 2006;15:577-583. (Pubitemid 44661744)
48. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review. Ann Rheum Dis 2010;69:20-28.
49. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000;27:1884-1891. (Pubitemid 30670481)
50. Alarcoń GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202. (Pubitemid 32954446)
51. Walsh SJ, Gilchrist A. Geographical clustering of mortality from systemic lupus erythematosus in the United States: Contributions of poverty. Hispanic ethnicity and solar radiation. Lupus 2006;15:662-670. (Pubitemid 44682828)
52. Durán S, Apte M, Alarcoń GS; LUMINA Study Group. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007;99:1196-1198. (Pubitemid 47614593)
53. Odutola J,Ward MM. Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol 2005;17:147-152. (Pubitemid 40279608)
54. Johnson SR, Urowitz MB, Ibañ ez D, Gladman DD. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol 2006;33:1990-1995. (Pubitemid 44571872)
55. Alarcoń GS, McGwin G Jr, Petri M, Ramsey-Goldman R, Fessler BJ, Vilá LM, Edberg JC, Reveille JD, Kimberly RP; PROFILE Study Group. Time to renal disease and end-stage renal disease in PROFILE: A multiethnic lupus cohort. PLoS Med 2006;3(10):e396.